Signals, Powered By EquityPandit
Jubilant Life Sciences is seeking shareholders approval through postal ballot/e-voting for raising up to Rs 1,000 crore by issuing non-convertible debentures (NCDs) on private placement basis.
Jubilant Life Science has said in a notice to shareholders filed to the BSE that ” In order to provide necessary flexibility regarding borrowings of the company in an optimal manner depending on the market conditions, the company proposes to offer, issue and allot redeemable NCDs up to Rs 1,000 crore.”
It further said that this approval to the board for raising the amount also stipulated that this could be done in one or more series/tranches during a period of one year from the date of passing the resolution.
